Patents by Inventor Mark A. Feitelson

Mark A. Feitelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250099410
    Abstract: The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.
    Type: Application
    Filed: December 10, 2024
    Publication date: March 27, 2025
    Inventors: Alla ARZUMANYAN, Ira C. Spector, Mark A. Feitelson
  • Publication number: 20250017883
    Abstract: The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.
    Type: Application
    Filed: September 30, 2024
    Publication date: January 16, 2025
    Inventors: Alla ARZUMANYAN, Ira C. Spector, Mark A. Feitelson
  • Publication number: 20240342122
    Abstract: The invention relates to compositions for preventing or delaying the onset of hepatocellular cancer. The compositions of the invention may comprise short chain fatty acids. The compositions of the invention may also comprise probiotic bacteria. The compositions of the invention include compositions for preventing or delaying the onset of hepatocellular cancer by treating or preventing liver inflammation, liver disease, and precancerous lesions.
    Type: Application
    Filed: March 19, 2024
    Publication date: October 17, 2024
    Inventor: Mark A. Feitelson
  • Patent number: 11963938
    Abstract: The invention relates to compositions for preventing or delaying the onset of hepatocellular cancer. The compositions of the invention may comprise short chain fatty acids. The compositions of the invention may also comprise probiotic bacteria. The compositions of the invention include compositions for preventing or delaying the onset of hepatocellular cancer by treating or preventing liver inflammation, liver disease, and precancerous lesions.
    Type: Grant
    Filed: July 19, 2021
    Date of Patent: April 23, 2024
    Assignee: Temple University-Of The Commonwealth System of Higher Education
    Inventor: Mark A. Feitelson
  • Publication number: 20240009155
    Abstract: The present disclosure describes compositions and methods for treating hepatitis B virus-associated hepatocellular carcinoma. Chronic infection with hepatitis B virus (HBV) is a major risk factor for the development of hepatocellular carcinoma (HCC). The HBV encoded oncoprotein, HBx, alters the expression of host genes and the activity of multiple signal transduction pathways. Short chain fatty acids can be used to delay or block the progression of chronic liver disease to HCC by targeting functions associated with HBx.
    Type: Application
    Filed: November 12, 2021
    Publication date: January 11, 2024
    Inventors: Mark A. Feitelson, Alla Arzumanyan, Ira Spector
  • Patent number: 11759442
    Abstract: The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.
    Type: Grant
    Filed: June 17, 2021
    Date of Patent: September 19, 2023
    Assignee: Temple University-Of The Commonwealth System of Higher Education
    Inventors: Ira C. Spector, Mark A. Feitelson, Alla Arzumanyan
  • Publication number: 20220142978
    Abstract: The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.
    Type: Application
    Filed: January 25, 2022
    Publication date: May 12, 2022
    Inventors: Alla ARZUMANYAN, Ira C. Spector, Mark A. Feitelson
  • Publication number: 20220008369
    Abstract: The invention relates to compositions for preventing or delaying the onset of hepatocellular cancer. The compositions of the invention may comprise short chain fatty acids. The compositions of the invention may also comprise probiotic bacteria. The compositions of the invention include compositions for preventing or delaying the onset of hepatocellular cancer by treating or preventing liver inflammation, liver disease, and precancerous lesions.
    Type: Application
    Filed: July 19, 2021
    Publication date: January 13, 2022
    Inventor: Mark A. Feitelson
  • Publication number: 20210338614
    Abstract: The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.
    Type: Application
    Filed: June 17, 2021
    Publication date: November 4, 2021
    Inventors: Ira C. Spector, Mark A. Feitelson, Alla Arzumanyan
  • Patent number: 11065217
    Abstract: The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: July 20, 2021
    Assignee: TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Inventors: Ira C. Spector, Mark A. Feitelson, Alla Arzumanyan
  • Publication number: 20190160031
    Abstract: The invention relates to compositions for preventing or delaying the onset of hepatocellular cancer. The compositions of the invention may comprise short chain fatty acids. The compositions of the invention may also comprise probiotic bacteria. The compositions of the invention include compositions for preventing or delaying the onset of hepatocellular cancer by treating or preventing liver inflammation, liver disease, and precancerous lesions.
    Type: Application
    Filed: January 30, 2019
    Publication date: May 30, 2019
    Inventor: Mark A. Feitelson
  • Patent number: 10231941
    Abstract: The invention relates to compositions for preventing or delaying the onset of hepatocellular cancer. The compositions of the invention may comprise short chain fatty acids. The compositions of the invention may also comprise probiotic bacteria. The compositions of the invention include compositions for preventing or delaying the onset of hepatocellular cancer by treating or preventing liver inflammation, liver disease, and precancerous lesions.
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: March 19, 2019
    Assignee: Temple University—Of The Commonwealth System of Higher Educaton
    Inventor: Mark A. Feitelson
  • Patent number: 10143669
    Abstract: The invention relates to compositions for preventing or delaying the onset of hepatocellular cancer. The compositions of the invention may comprise short chain fatty acids. The compositions of the invention may also comprise probiotic bacteria. The compositions of the invention include compositions for preventing or delaying the onset of hepatocellular cancer by treating or preventing liver inflammation, liver disease, and precancerous lesions.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: December 4, 2018
    Assignee: Temple University—Of The Commonwealth System of Higher Education
    Inventor: Mark A. Feitelson
  • Publication number: 20180214399
    Abstract: The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.
    Type: Application
    Filed: February 23, 2018
    Publication date: August 2, 2018
    Inventors: Ira C. Spector, Mark A. Feitelson, Alla Arzumanyan
  • Publication number: 20180185307
    Abstract: The invention relates to compositions for preventing or delaying the onset of hepatocellular cancer. The compositions of the invention may comprise short chain fatty acids. The compositions of the invention may also comprise probiotic bacteria. The compositions of the invention include compositions for preventing or delaying the onset of hepatocellular cancer by treating or preventing liver inflammation, liver disease, and precancerous lesions.
    Type: Application
    Filed: February 23, 2018
    Publication date: July 5, 2018
    Inventors: Mark A. Feitelson, Helena M.G.P.V. Reis
  • Publication number: 20180008565
    Abstract: The invention relates to compositions for preventing or delaying the onset of hepatocellular cancer. The compositions of the invention may comprise short chain fatty acids. The compositions of the invention may also comprise probiotic bacteria. The compositions of the invention include compositions for preventing or delaying the onset of hepatocellular cancer by treating or preventing liver inflammation, liver disease, and precancerous lesions.
    Type: Application
    Filed: January 21, 2016
    Publication date: January 11, 2018
    Inventors: Mark A. Feitelson, Helena M.G.P.V. Reis